Company news
4DMedical Ltd. news in 2026
4DMedical Ltd.'s news releases, calls and decks from 2026, newest first.
Becoming a substantial holder
November 4, 2026
Response to ASX Price Query
November 1, 2026
Response to ASX Price Query
November 1, 2026
Pause in Trading
November 1, 2026
Application for quotation of securities - 4DX
October 30, 2026
Final Director's Interest Notice -LB
October 30, 2026
Results of AGM
October 27, 2026
Quarterly Activity Report and Appendix 4C
October 27, 2026
Quarterly Activity Report and Appendix 4C
October 27, 2026
AGM Presentation and Chair's address
October 27, 2026
Notice of 2026 Annual General Meeting - Clarification
October 23, 2026
Application for quotation of securities - 4DX
October 16, 2026
Addendum to 2026 Notice of Annual General Meeting
October 15, 2026
Notification of cessation of securities - 4DX
October 2, 2026
Application for quotation of securities - 4DX
October 2, 2026
Ceasing to be a substantial holder
September 27, 2026
Becoming a substantial holder
September 24, 2026
Notice of Annual General Meeting/Proxy Form
September 23, 2026
Appendix 4G and Corporate Governance Statement
September 23, 2026
FY26 Annual Report
September 23, 2026
Initial Director's Interest Notice - CJ
September 23, 2026
Board transition and key personnel appointments
September 23, 2026
Ceasing to be a substantial holder
September 22, 2026
Application for quotation of securities - 4DX
September 18, 2026
Cleansing Notice
September 4, 2026
Application for quotation of securities - 4DX
September 4, 2026
Notification of Date of 2026 AGM
August 28, 2026
FY2026 Full year results
August 27, 2026
Appendix 4E - Preliminary Final Report
August 27, 2026
Azra AI and 4DMedical Partner to Bring Enterprise-Wide Lung Health Intelligence to Health Systems
August 17, 2026
Application for quotation of securities - 4DX
August 14, 2026
Cleansing Notice
August 13, 2026
Application for quotation of securities - 4DX
August 13, 2026
Update - Proposed issue of securities - 4DX
August 10, 2026
Update - Proposed issue of securities - 4DX
July 31, 2026
Quarterly Activity Report and Appendix 4C
July 30, 2026
US Bill directs VA to adopt 4D lung imaging
July 15, 2026
Pause in trade
July 15, 2026
4DMedical Receives TGA Approval for CT: VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia
June 28, 2026
4DMedical receives TGA approval for CTVQ in Australia
June 25, 2026
4DMedical targets US$2.5B PE market entry for CTVQ
June 1, 2026
4DMedical creates EU platform via contextflow acquisition
May 31, 2026
CTVQ enters US Outpatient Market via SimonMed 170 sites
May 28, 2026
Major publication validates CTVQ for lung surgery
May 19, 2026
GSK contract, UK clearance for CTVQ, and ASX 200 inclusion
April 20, 2026
Insignia Financial to be removed from the S&P/ASX 200 Index
April 13, 2026
4DMedical receives CE Mark for CT: VQ™, enabling commercial launch across the European Union
March 30, 2026
CE Mark for CTVQ and $83M placement to fund EU expansion
March 26, 2026
CTVQ deployed at Mayo Clinic
March 24, 2026
Update - S&P DJI March 2026 Rebalance of the All Ordinaries
March 10, 2026
Decks in 2026
- Shareholder Meeting (October 2026)
Shareholder meeting · 40 slides · Oct 28, 2026
- Investor Presentation (January 2026)
Investor deck · 20 slides · Jan 19, 2026